FDAClass IIAugust 14, 2013

Merrem I.v recall

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS…

Why was Merrem I.v recalled?

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015

Product
MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS…
Recalling firm
AstraZeneca Pharmaceuticals LP
Quantity
81,900 total vials
Distribution
USA and Puerto Rico
Recall date
August 14, 2013
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls